We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Angled Support Catheter Assists Peripheral Vascular Procedures

By HospiMedica International staff writers
Posted on 18 Oct 2016
A new angled support catheter assists clinicians during endovascular procedures to treat complex peripheral artery disease (PAD).

The Medtronic (Dublin, Ireland) TrailBlazer angled peripheral support catheter is an over-the-wire single lumen seamless catheter designed for high visibility, optimal wire support, and ease of lesion entry for difficult to cross lesions. More...
Thanks to the atraumatic tapered tip, a lubricious inner layer, and CrossCoat hydrophilic coating on the distal 40 cm, TrailBalizer can smoothly track through challenging vasculature. To enhance fluoroscopic visibility, the TrailBlazer .014", .018", and .035" guidewire compatible devices have three embedded radiopaque marker bands and a radiopaque shaft.

The TrailBlazer is designed to not only support a guidewire during access to peripheral arteries, but also to enable delivery of solutions and diagnostic agents. The catheter features a braided stainless steel shaft for robust pushability and kink resistance, and a 25 and 30 degree angled tapered tip to access and cross complex lesions. Both the .014" and .018" TrailBlazer support catheters can fit coaxially through the .035" support catheter for increased reach and higher pushability.

“Medtronic is committed to providing physicians with meaningful innovations and therapy choices to enhance their peripheral treatment algorithm,” said Mark Pacyna, vice president and general manager of the peripheral business at Medtronic. “Working with physicians, we have extended the Medtronic TrailBlazer support catheter portfolio to offer a broad suite of angled options for treatment of complex lesions both above and below the knee.”

PAD is a narrowing of the peripheral arteries due to atherosclerosis, and is most common in the arteries of the pelvis and legs. The most common symptoms of PAD are cramping, pain, or tiredness in the leg or hip muscles while walking or climbing stairs, which is temporarily relieved by rest. PAD sufferers have four to five times more risk of heart attack or stroke, and if left untreated, it can lead to gangrene and amputation.

Related Links:
Medtronic


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.